Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry

國藥科技股份(08156.HK)與貴州中小微企業商會簽署戰略合作協議
National Pharmaceutical Science and Technology Co., Ltd. (08156.HK) signs strategic cooperation agreement with Guizhou Chamber of Commerce for small and medium-sized Enterprises

即市頭條 ·  {{timeTz}}

國藥科技股份(08156.HK)公布,公司之全資子公司與貴州省中小微企業商會已簽署戰略合作協議,雙方將合作,實現國科防偽創新型防偽產品項目在貴州省的落地實施和銷售渠道拓展、為集團尋找合適的企業客戶,以及努力促成集團與企業客戶達成交易。

Sinopharm Technology Co., Ltd. (08156.HK) announced that a wholly-owned subsidiary of the company and the Guizhou Provincial Chamber of Commerce of small and medium-sized Enterprises have signed a strategic cooperation agreement, and the two sides will cooperate to realize the implementation and sales channel expansion of Sinopec's anti-counterfeiting innovative anti-counterfeiting product project in Guizhou Province, to find suitable corporate customers for the Group, and to strive to facilitate a transaction between the Group and corporate customers.

This page is machine-translated. Moomoo tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal.


Moomoo is a financial information and trading app offered by Moomoo Techonologies Inc.


In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).


In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. ("Moomoo Financial SG") regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial SG is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.


In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.